APOE and Alzheimer disease: While some studies reported ApoE targeting as a therapeutic approach to reduce Aβ aggregates [102, 106, 108, 109], ApoE deletion results in improved neuronal responses, reduced neuritic plaques, reactive glia and synaptic loss in a transgenic mouse model of AD [110]..